3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Gynecologic Cancer
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
olaparib
2
ulipristal acetate
1
pembrolizumab
1
durvalumab
1
camrelizumab
1
apatinib
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sentinel Lymph Node Biopsy
1
Robotic Surgical Procedures
1
Radiation Dose Hypofractionation
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Paclitaxel
1
Mindfulness
1
Immune Checkpoint Inhibitors
1
Hysteroscopy
1
Hyperthermic Intraperitoneal Chemotherapy
1
Health
1
Exercise
1
Enhanced Recovery After Surgery
1
Clinical Protocols
1
Carboplatin
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uterine Neoplasms
×
Enhanced Recovery After Surgery
×
Clear all
NCT04063072
2021-06-02
ERAS-Gyneco
Ospedale Regina Montis Regalis
Phase NA
Unknown
1,800 enrolled